NEW YORK (GenomeWeb News) — Synthetic genetics company Codon Devices has pocketed $20 million in a Series B round of venture capital financing, Codon said today.
 
Codon CEO John Danner said the company will use the cash to develop its BioFAB production platform, which uses informatics, robotics, and sequencing technology to synthesize gene codes.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.